Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Semin Nucl Med
    October 2025
  1. HIGUCHI T, Chen X, Siegmund SC, Klimek K, et al
    Recent Advances and Future Trends of[(18)F]-Labeled PET Agents for Renal Imaging.
    Semin Nucl Med. 2025 Oct 15:S0001-2998(25)00124.
    >> Share

    September 2025
  2. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    >> Share

  3. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    >> Share

    July 2025
  4. NYAKALE N, Maes A, Sathekge M, Li S, et al
    PSMA-Targeted Positron Emission Tomography Imaging in Solid Tumors Other Than Prostate Carcinoma: An Update.
    Semin Nucl Med. 2025 Jul 19:S0001-2998(25)00070.
    >> Share

  5. SAFARIAN A, Mirshahvalad SA, Farbod A, Jung T, et al
    Artificial Intelligence for Tumor [(18)F]FDG PET Imaging: Advancements and Future Trends - Part II.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00086.
    >> Share

  6. NOVRUZOV E, Mamlins E, Mori Y, Cardinale J, et al
    The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00090.
    >> Share

  7. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00069.
    >> Share

  8. PABST KM, Fendler WP, Jochheim LS, Herrmann K, et al
    The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00075.
    >> Share

  9. LIN W, Huang C, Tan Z, Xu H, et al
    Cu(II)-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases.
    Semin Nucl Med. 2025;55:577-586.
    >> Share

  10. FILIPPI L, Schillaci O
    Global experience in brain amyloid imaging.
    Semin Nucl Med. 2025;55:538-547.
    >> Share

    June 2025
  11. FERRANDO R, Hernandes D, Ghini BG, Coutinho AM, et al
    PET Imaging in Psychiatric Disorders.
    Semin Nucl Med. 2025 Jun 20:S0001-2998(25)00068.
    >> Share

  12. RYU J, Oh M
    Positron Emission Tomography in Autism Spectrum Disorder: Current Status and Future Perspectives.
    Semin Nucl Med. 2025 Jun 12:S0001-2998(25)00065.
    >> Share

  13. STORMEZAND GN, Doorduin J, Glaudemans AWJM, van der Hoorn A, et al
    Current Developments on [(18)F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System.
    Semin Nucl Med. 2025 Jun 11:S0001-2998(25)00066.
    >> Share

  14. YANG YJ, Zhao YX, Li XY, Zuo C, et al
    New Targets for Positron Emission Tomography Imaging in Parkinson s Disease.
    Semin Nucl Med. 2025 Jun 6:S0001-2998(25)00061.
    >> Share

  15. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
    Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
    >> Share

    May 2025
  16. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
    Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
    >> Share

  17. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
    >> Share

  18. BENDER D
    New Radiopharmaceutical Tools in Imaging.
    Semin Nucl Med. 2025 May 26:S0001-2998(25)00059.
    >> Share

  19. BARANSKA K, Niemas K, Pelka K, Kunikowska J, et al
    PET/CT in the Imaging of CNS Tumors.
    Semin Nucl Med. 2025 May 21:S0001-2998(25)00040.
    >> Share

  20. LIN Z, Rasinski P, Nilsson T, Holstensson M, et al
    FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.
    Semin Nucl Med. 2025 May 20:S0001-2998(25)00056.
    >> Share

  21. BRINK A, Paez D, Estrada Lobato E, Delgado Bolton RC, et al
    New Targets for Imaging in Nuclear Medicine.
    Semin Nucl Med. 2025 May 6:S0001-2998(25)00039.
    >> Share

  22. NERATTINI M, Abenavoli EM, Berti V
    PET/CT in Movement Disorders: Update.
    Semin Nucl Med. 2025 May 3:S0001-2998(25)00036.
    >> Share

  23. CAIRNS J, Frood R, Patel C, Scarsbrook A, et al
    The Role of AI in Lymphoma: An Update.
    Semin Nucl Med. 2025;55:377-386.
    >> Share

  24. EJAZ A, Naqvi AH, Perumalla HS, Bateman TM, et al
    Assessment of Myocardial Perfusion in Patients After CABG: An Update and Clinical Implications.
    Semin Nucl Med. 2025;55:460-469.
    >> Share

    April 2025
  25. SPOHN SKB, Grosu AL
    Impact of PSMA PET on Radiation Oncology Planning.
    Semin Nucl Med. 2025 Apr 22:S0001-2998(25)00034.
    >> Share

  26. VANDERLINDEN G, Vandenberghe R, Vandenbulcke M, Van Laere K, et al
    The Current Role of Tau PET Imaging in Neurodegeneration.
    Semin Nucl Med. 2025 Apr 21:S0001-2998(25)00031.
    >> Share

  27. YANG F, Lei B, Zhou Z, Song TA, et al
    AI in SPECT Imaging: Opportunities and Challenges.
    Semin Nucl Med. 2025 Apr 3:S0001-2998(25)00033.
    >> Share

    March 2025
  28. SAFARIAN A, Mirshahvalad SA, Farbod A, Nasrollahi H, et al
    Artificial intelligence for tumor [(18)F]FDG-PET imaging: Advancement and future trends-part I.
    Semin Nucl Med. 2025 Mar 29:S0001-2998(25)00032.
    >> Share

  29. KIRIENKO M, Cavinato L, Sollini M
    Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence.
    Semin Nucl Med. 2025 Mar 21:S0001-2998(25)00021.
    >> Share

  30. RICHLITZKI C, Manapov F, Holzgreve A, Rabe M, et al
    Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
    Semin Nucl Med. 2025 Mar 9:S0001-2998(25)00022.
    >> Share

  31. CANGUT B, Akinlusi R, Mohseny A, Ghesani N, et al
    Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00013.
    >> Share

  32. MIKKELSEN AFS, Thygesen J, Fledelius J
    Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00015.
    >> Share

  33. SAFARIAN A, Mirshahvalad SA, Nasrollahi H, Jung T, et al
    Impact of [(18)F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00014.
    >> Share

  34. ALORFI F, Bomanji J, Bertoletti L, Fraioli F, et al
    PET/MRI in Non-Small Cell Lung Cancer (NSCLC).
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00019.
    >> Share

  35. DELEU AL, Shagera QA, Veldhuijzen van Zanten S, Flamen P, et al
    FAPI PET in the Management of Lung Tumors.
    Semin Nucl Med. 2025 Mar 3:S0001-2998(25)00018.
    >> Share

    February 2025
  36. SATHEKGE C, Maes J, Maes A, Van de Wiele C, et al
    FDG PET/CT for Staging Lung Carcinoma: An Update.
    Semin Nucl Med. 2025 Feb 28:S0001-2998(25)00003.
    >> Share

  37. AYENI A, Evbuomwan O, Vangu MW
    The Role of [(18)F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00010.
    >> Share

  38. BADARNA M, Keidar Z, Arnon-Sheleg E
    Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00009.
    >> Share

  39. VINJAMURI S, Pant V
    Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
    Semin Nucl Med. 2025 Feb 26:S0001-2998(25)00011.
    >> Share

  40. CURRIE GM, Rohren EM
    Potential of Technetium and Rhenium Theranostics.
    Semin Nucl Med. 2025 Feb 24:S0001-2998(25)00006.
    >> Share

  41. LOPES L, Lopez-Montes A, Chen Y, Koller P, et al
    The Evolution of Artificial Intelligence in Nuclear Medicine.
    Semin Nucl Med. 2025 Feb 10:S0001-2998(25)00005.
    >> Share

    January 2025
  42. LIU J, Sandhu K, Woon DTS, Perera M, et al
    The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
    Semin Nucl Med. 2025 Jan 31:S0001-2998(24)00120.
    >> Share

  43. MOHSENINIA N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, et al
    Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
    Semin Nucl Med. 2025 Jan 23:S0001-2998(25)00001.
    >> Share

    December 2024
  44. SACHPEKIDIS C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A, et al
    Radiomics and Artificial Intelligence Landscape for [(18)F]FDG PET/CT in Multiple Myeloma.
    Semin Nucl Med. 2024 Dec 13:S0001-2998(24)00111.
    >> Share

    November 2024
  45. RATHOD N, Jutidamrongphan W, Bosbach WA, Chen Y, et al
    Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging.
    Semin Nucl Med. 2024 Nov 29:S0001-2998(24)00110.
    >> Share

  46. ZOGHI S, Mingels C, Badawi RD, Spencer BA, et al
    Role of Total Body PET/CT in Inflammatory Disorders.
    Semin Nucl Med. 2024 Nov 21:S0001-2998(24)00107.
    >> Share

  47. HAWK KE, Currie GM
    Artificial Intelligence and Workforce Diversity in Nuclear Medicine.
    Semin Nucl Med. 2024 Nov 19:S0001-2998(24)00090.
    >> Share

  48. GERKE O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, et al
    Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[(18)F]FDG-PET/CT, (18)F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone Scintigraphy.
    Semin Nucl Med. 2024 Nov 14:S0001-2998(24)00093.
    >> Share

  49. DIAS AH, Andersen KF, Fosbol MO, Gormsen LC, et al
    Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00092.
    >> Share

  50. GODINEZ F, Mingels C, Bayerlein R, Mehadji B, et al
    Total Body PET/CT: Future Aspects.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00096.
    >> Share

  51. MARTINEZ-LUCIO TS, Mendoza-Ibanez OI, Liu W, Mostafapour S, et al
    Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
    Semin Nucl Med. 2024 Nov 12:S0001-2998(24)00094.
    >> Share

  52. YANG N, Guo XY, Ding J, Wang F, et al
    Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational.
    Semin Nucl Med. 2024 Nov 8:S0001-2998(24)00086.
    >> Share

  53. NANNI C, Farolfi A, Castellucci P, Fanti S, et al
    Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology.
    Semin Nucl Med. 2024 Nov 7:S0001-2998(24)00091.
    >> Share

  54. DEV ID, Puranik AD, Singh B, Prasad V, et al
    Current and Future Perspectives of PDL1 PET and SPECT Imaging.
    Semin Nucl Med. 2024 Nov 6:S0001-2998(24)00084.
    >> Share

  55. LIN Y, Gao H, Zheng J, Al-Ibraheem A, et al
    Clinical Explorations of [(68)Ga] Ga-FAPI-04 and [(18)F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.
    Semin Nucl Med. 2024 Nov 2:S0001-2998(24)00085.
    >> Share

  56. MENA E, Lindenberg L, Choyke PL
    Update on PSMA-based Prostate Cancer Imaging.
    Semin Nucl Med. 2024;54:941-950.
    >> Share

  57. O'BRIEN SR, Edmonds CE, Ward RE, Taunk NK, et al
    Update on (18)F-Fluoroestradiol.
    Semin Nucl Med. 2024;54:812-826.
    >> Share

    October 2024
  58. CUMBERS GA, Harvey-Latham ED, Kassiou M, Werry EL, et al
    Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.
    Semin Nucl Med. 2024 Oct 29:S0001-2998(24)00082.
    >> Share

  59. DUVENHAGE J, Kahts M, Summers B, Zeevaart JR, et al
    Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies.
    Semin Nucl Med. 2024 Oct 26:S0001-2998(24)00088.
    >> Share

  60. NOGUEIRA-LIMA E, Alves T, Etchebehere E
    (18)F-Fluoride PET/CT-Updates.
    Semin Nucl Med. 2024 Oct 10:S0001-2998(24)00083.
    >> Share

  61. MENG X, Kong X, Wu R, Yang Z, et al
    Total Body PET/CT: A Role in Drug Development?
    Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00081.
    >> Share

  62. STORMEZAND GN, de Meyer E, Koopmans KP, Brouwers AH, et al
    Update on the Role of [(18)F]FDOPA PET/CT.
    Semin Nucl Med. 2024 Oct 8:S0001-2998(24)00080.
    >> Share

  63. AL-IBRAHEEM A, Abdlkadir AS, Shi H, Abdel-Razeq H, et al
    PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [(68)Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis.
    Semin Nucl Med. 2024 Oct 5:S0001-2998(24)00079.
    >> Share

  64. ZHANG Q, Huang Z, Jin Y, Li W, et al
    Total-Body PET/CT: A Role of Artificial Intelligence?
    Semin Nucl Med. 2024 Oct 4:S0001-2998(24)00078.
    >> Share

    September 2024
  65. MINGELS C, Chung KJ, Pantel AR, Rominger A, et al
    Total-Body PET/CT: Challenges and Opportunities.
    Semin Nucl Med. 2024 Sep 27:S0001-2998(24)00076.
    >> Share

  66. NOSKOVICOVA L, Balogova S, Aveline C, Tassart M, et al
    (18)F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
    Semin Nucl Med. 2024 Sep 20:S0001-2998(24)00075.
    >> Share

  67. HICKS RJ, Ware RE, Callahan J
    Total-Body PET/CT: Pros and Cons.
    Semin Nucl Med. 2024 Sep 16:S0001-2998(24)00065.
    >> Share

  68. NAYFEH M, Sayed A, Alwan M, Alfawara M, et al
    Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging.
    Semin Nucl Med. 2024;54:638-647.
    >> Share

  69. CLERC OF, Vijayakumar S, Dorbala S
    Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
    Semin Nucl Med. 2024;54:717-732.
    >> Share

  70. MILLER RJH, Slomka PJ
    Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends.
    Semin Nucl Med. 2024;54:648-657.
    >> Share

    August 2024
  71. COURAULT P, Zimmer L, Lancelot S
    Toward Functional PET Imaging of the Spinal Cord.
    Semin Nucl Med. 2024 Aug 23:S0001-2998(24)00066.
    >> Share

    July 2024
  72. WAHL RL, Kahl B
    The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
    Semin Nucl Med. 2024 Jul 16:S0001-2998(24)00055.
    >> Share

  73. KLEYNHANS J, Ebenhan T, Sathekge MM
    Expanding Role for Gallium-68 PET Imaging in Oncology.
    Semin Nucl Med. 2024 Jul 3:S0001-2998(24)00054.
    >> Share

  74. SATHEKGE MM, Bouchelouche K
    Letter from the Editors.
    Semin Nucl Med. 2024;54:457-459.
    >> Share

    June 2024
  75. KATAL S, Patel P, Lee J, Taubman K, et al
    Total Body PET/CT: A Role in Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Jun 28:S0001-2998(24)00049.
    >> Share

  76. MAHAJAN S, Gavane S, Pandit-Taskar N
    Targeted Radiopharmaceutical Therapy for Bone Metastases.
    Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
    >> Share

  77. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
    Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
    Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
    >> Share

  78. KAZIMIERCZYK R, Kaminski KA, Nekolla SG
    Cardiac PET/MRI: Recent Developments and Future Aspects.
    Semin Nucl Med. 2024 Jun 8:S0001-2998(24)00048.
    >> Share

  79. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
    Total Body PET-CT Protocols in Oncology.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00050.
    >> Share

  80. CURRIE GM, Hawk KE, Rohren EM
    Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00046.
    >> Share

  81. SACHPEKIDIS C, Dimitrakopoulou-Strauss A
    Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer.
    Semin Nucl Med. 2024 Jun 1:S0001-2998(24)00045.
    >> Share

    May 2024
  82. BOUCHELOUCHE K, Sathekge MM
    Letter from the Editors.
    Semin Nucl Med. 2024;54:311-312.
    >> Share

  83. HABERL C, Crean AM, Zelt JGE, Redpath CJ, et al
    Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia.
    Semin Nucl Med. 2024;54:427-437.
    >> Share

    April 2024
  84. PAEZ D, Giammarile F, Brink A, Garcia-Perez O, et al
    The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00032.
    >> Share

  85. GUJA KE, Behr G, Bedmutha A, Kuhn M, et al
    Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00030.
    >> Share

    March 2024
  86. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
    Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
    Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
    >> Share

  87. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
    FAPI-PET in Cardiovascular Disease.
    Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
    >> Share

  88. GUJA KE, Ganjoo KN, Iagaru A
    Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
    Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
    >> Share

  89. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
    Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
    Semin Nucl Med. 2024;54:237-246.
    >> Share

  90. EVANGELISTA L, Israel O
    Letter From the Guest Editors.
    Semin Nucl Med. 2024;54:181-182.
    >> Share

  91. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
    Functional Imaging in Musculoskeletal Disorders in Menopause.
    Semin Nucl Med. 2024;54:206-218.
    >> Share

    February 2024
  92. KHALATBARI H, Shulkin BL, Parisi MT
    PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
    Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
    >> Share

  93. ULANER GA, Vaz SC
    Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
    Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
    >> Share

  94. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
    Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
    >> Share

  95. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
    Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
    >> Share

  96. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
    Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
    >> Share

    January 2024
  97. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
    The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
    Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
    >> Share

  98. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
    SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
    Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
    >> Share

    December 2023
  99. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
    How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
    Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
    >> Share

  100. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
    What Role Does PET/MRI Play in Musculoskeletal Disorders?
    Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
    >> Share

    November 2023
  101. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
    [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
    Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
    >> Share

  102. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
    PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
    Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
    >> Share

  103. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
    Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
    Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
    >> Share

  104. VOTER AF, Werner RA, Savas H, Gafita A, et al
    A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
    Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
    >> Share

  105. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
    PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
    Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
    >> Share

  106. CARACCIOLO M, Castello A, Lopci E
    PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
    Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
    >> Share

  107. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
    Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
    Semin Nucl Med. 2023;53:733-742.
    >> Share

  108. LOW CS, Rao N
    Imaging of Gastrointestinal Bleeding: An Update.
    Semin Nucl Med. 2023;53:766-776.
    >> Share

  109. SIRAJ QH
    Functional Imaging of Testicular Torsion.
    Semin Nucl Med. 2023;53:797-808.
    >> Share

  110. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
    Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
    Semin Nucl Med. 2023;53:743-751.
    >> Share

  111. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
    The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
    Semin Nucl Med. 2023;53:752-765.
    >> Share

  112. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
    Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
    Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
    >> Share

    September 2023
  113. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
    Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016